Edwards Lifesciences Corporation Investment Income, Interest
Edwards Lifesciences Corporation (EW) reported Investment Income, Interest of $30.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-04
- Edwards Lifesciences Corporation investment income, interest for the quarter ending 2026-06-30 was $30.00M, a 19.79% decline year-over-year.
- Edwards Lifesciences Corporation investment income, interest for the quarter ending 2026-03-31 was $33.50M, a 8.22% decline year-over-year.
- Edwards Lifesciences Corporation investment income, interest for the quarter ending 2025-06-30 was $37.40M.
- Edwards Lifesciences Corporation investment income, interest for the quarter ending 2025-03-31 was $36.50M.
- Edwards Lifesciences Corporation investment income, interest for fiscal 2025 was $168.80M, a 40.32% increase from fiscal 2024.
- Edwards Lifesciences Corporation investment income, interest for fiscal 2024 was $120.30M, a 79.02% increase from fiscal 2023.
- Edwards Lifesciences Corporation investment income, interest for fiscal 2023 was $67.20M, a 89.30% increase from fiscal 2022.
- Edwards Lifesciences Corporation investment income, interest for fiscal 2022 was $35.50M, a 104.02% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 12 month |
|---|---|---|---|
| 2026-06-30 | $30.00M 10-Q · filed 2026-08-04 | $63.50M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $33.50M 10-Q · filed 2026-05-06 | ||
| 2025-12-31 | $168.80M 10-K · filed 2026-02-25 | ||
| 2025-06-30 | $37.40M 10-Q · filed 2026-08-04 | $73.90M 10-Q · filed 2026-08-04 | |
| 2025-03-31 | $36.50M 10-Q · filed 2026-05-06 | ||
| 2024-12-31 | $120.30M 10-K · filed 2026-02-25 | ||
| 2023-12-31 | $67.20M 10-K · filed 2026-02-25 | ||
| 2022-12-31 | $35.50M 10-K · filed 2025-02-28 | ||
| 2021-12-31 | $17.40M 10-K · filed 2024-02-12 | ||
| 2020-12-31 | $23.40M 10-K · filed 2023-02-13 | ||
| 2019-12-31 | $32.20M 10-K · filed 2022-02-14 | ||
| 2018-12-31 | $32.00M 10-K · filed 2021-02-12 | ||
| 2017-12-31 | $20.30M 10-K · filed 2020-02-14 | ||
| 2016-12-31 | $10.80M 10-K · filed 2019-02-15 | ||
| 2015-12-31 | $7.90M 10-K · filed 2018-02-16 | ||
| 2014-12-31 | $6.40M 10-K · filed 2017-02-17 | ||
| 2013-12-31 | $4.60M 10-K · filed 2016-02-19 | ||
| 2012-12-31 | $4.80M 10-K · filed 2015-02-20 | ||
| 2011-12-31 | $3.40M 10-K · filed 2014-02-28 | ||
| 2010-12-31 | $900.00K 10-K · filed 2013-02-28 | ||
| 2009-12-31 | $1.60M 10-K · filed 2012-02-27 | ||
| 2008-12-31 | $6.10M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |